Cryoglobulinaemia in Sjogren — SCE Rheumatology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Type II (monoclonal IgM with rheumatoid factor activity against polyclonal IgG)
The best answer is “Type II (monoclonal IgM with rheumatoid factor activity against polyclonal IgG)”. Type II (monoclonal IgM with rheumatoid factor activity against polyclonal IgG) is supported by the cited UK or directly applicable specialist authority and best matches the tested threshold, complication or monitoring principle. The remaining choices—“No cryoglobulinaemia occurs in Sjogren, after safety review, after specialist assessment”, “Type IV, after specialist assessment, after specialist assessment, with clinical reassessment”, “Type I (monoclonal immunoglobulin), with clinical reassessment, within a rheumatology pathway”, “Type III (polyclonal IgM against polyclonal IgG), within a rheumatology pathway”—are credible in related rheumatology presentations, but each addresses a different diagnosis, investigation, treatment sequence or complication and does not fit the decisive findings in this stem.
Reference: BSR guideline on Sjögren disease: https://academic.oup.com/rheumatology/article/64/2/409/7645909